Literature DB >> 31276426

Clinical-radiomics nomograms for pre-operative differentiation of sacral chordoma and sacral giant cell tumor based on 3D computed tomography and multiparametric magnetic resonance imaging.

Ping Yin1, Ning Mao2, Sicong Wang3, Chao Sun1, Nan Hong1.   

Abstract

OBJECTIVE: To develop and validate clinical-radiomics nomograms based on three-dimensional CT and multiparametric MRI (mpMRI) for pre-operative differentiation of sacral chordoma (SC) and sacral giant cell tumor (SGCT).
METHODS: A total of 83 SC and 54 SGCT patients diagnosed through surgical pathology were retrospectively analyzed. We built six models based on CT, CT enhancement (CTE), T1 weighted, T2 weighted, diffusion-weighted imaging (DWI), and contrast-enhanced T1 weighted features, two radiomics nomograms and two clinical-radiomics nomograms combined radiomics mixed features with clinical data. The area under the receiver operating characteristic curve (AUC) and accuracy (ACC) analysis were used to assess the performance of the models.
RESULTS: SC and SGCT presented significant differences in terms of age, sex, and tumor location (tage = 9.00, χ2sex = 10.86, χ2location = 26.20; p < 0.01). For individual scan, the radiomics model based on diffusion-weighted imaging features yielded the highest AUC of 0.889 and ACC of 0.885, followed by CT (AUC = 0.857; ACC = 0.846) and CT enhancement (AUC = 0.833; ACC = 0.769). For the combined features, the radiomics model based on mixed CT features exhibited a better AUC of 0.942 and ACC of 0.880, whereas mixed MRI features achieved a lower performance than the individual scan. The clinical-radiomics nomogram based on combined CT features achieved the highest AUC of 0.948 and ACC of 0.920.
CONCLUSIONS: The radiomics model based on CT and multiparametricMRI present a certain predictive value in distinguishing SC and SGCT, which can be used for auxiliary diagnosis before operation. The clinical-radiomics nomograms performed better than radiomics nomograms. ADVANCES IN KNOWLEDGE: Clinical-radiomics nomograms based on CT and mpMRI features can be used for preoperative differentiation of SC and SGCT.

Entities:  

Mesh:

Year:  2019        PMID: 31276426      PMCID: PMC6732930          DOI: 10.1259/bjr.20190155

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  40 in total

1.  Diagnostic value of open and needle biopsies in tumors of the sacrum.

Authors:  Remzi A Ozerdemoglu; Roby C Thompson; Ensor E Transfeldt; Edward Y Cheng
Journal:  Spine (Phila Pa 1976)       Date:  2003-05-01       Impact factor: 3.468

2.  A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.

Authors:  Shaoxu Wu; Junjiong Zheng; Yong Li; Hao Yu; Siya Shi; Weibin Xie; Hao Liu; Yangfan Su; Jian Huang; Tianxin Lin
Journal:  Clin Cancer Res       Date:  2017-09-05       Impact factor: 12.531

3.  [Imaging of sacral chordoma: comparison between MRI and CT].

Authors:  C Plathow; M-A Weber; J Debus; H-U Kauczor
Journal:  Radiologe       Date:  2005-01       Impact factor: 0.635

4.  Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

Authors:  Zhenyu Liu; Xiao-Yan Zhang; Yan-Jie Shi; Lin Wang; Hai-Tao Zhu; Zhenchao Tang; Shuo Wang; Xiao-Ting Li; Jie Tian; Ying-Shi Sun
Journal:  Clin Cancer Res       Date:  2017-09-22       Impact factor: 12.531

5.  Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.

Authors:  Yanqi Huang; Zaiyi Liu; Lan He; Xin Chen; Dan Pan; Zelan Ma; Cuishan Liang; Jie Tian; Changhong Liang
Journal:  Radiology       Date:  2016-06-27       Impact factor: 11.105

6.  Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.

Authors:  Scott L Zuckerman; Mark H Bilsky; Ilya Laufer
Journal:  World Neurosurg       Date:  2018-02-25       Impact factor: 2.104

7.  Multiparametric MR Imaging of Diffusion and Perfusion in Contrast-enhancing and Nonenhancing Components in Patients with Glioblastoma.

Authors:  Natalie R Boonzaier; Timothy J Larkin; Tomasz Matys; Anouk van der Hoorn; Jiun-Lin Yan; Stephen J Price
Journal:  Radiology       Date:  2017-02-27       Impact factor: 11.105

8.  Morphometric model for discrimination between glioblastoma multiforme and solitary metastasis using three-dimensional shape analysis.

Authors:  Guang Yang; Timothy L Jones; Franklyn A Howe; Thomas R Barrick
Journal:  Magn Reson Med       Date:  2015-07-14       Impact factor: 4.668

9.  Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy.

Authors:  Sean D McGarry; Sarah L Hurrell; Amy L Kaczmarowski; Elizabeth J Cochran; Jennifer Connelly; Scott D Rand; Kathleen M Schmainda; Peter S LaViolette
Journal:  Tomography       Date:  2016-09

10.  Radiomics based targeted radiotherapy planning (Rad-TRaP): a computational framework for prostate cancer treatment planning with MRI.

Authors:  Rakesh Shiradkar; Tarun K Podder; Ahmad Algohary; Satish Viswanath; Rodney J Ellis; Anant Madabhushi
Journal:  Radiat Oncol       Date:  2016-11-10       Impact factor: 3.481

View more
  7 in total

1.  Differentiation of paediatric posterior fossa tumours by the multiregional and multiparametric MRI radiomics approach: a study on the selection of optimal multiple sequences and multiregions.

Authors:  Jie Dong; Suxiao Li; Lei Li; Shengxiang Liang; Bin Zhang; Yun Meng; Xiaofang Zhang; Yong Zhang; Shujun Zhao
Journal:  Br J Radiol       Date:  2021-11-19       Impact factor: 3.039

2.  Prediction of the early recurrence in spinal giant cell tumor of bone using radiomics of preoperative CT: Long-term outcome of 62 consecutive patients.

Authors:  Qizheng Wang; Yang Zhang; Enlong Zhang; Xiaoying Xing; Yongye Chen; Min-Ying Su; Ning Lang
Journal:  J Bone Oncol       Date:  2021-03-16       Impact factor: 4.072

3.  CT-Based Radiomics Signatures for Predicting the Risk Categorization of Thymic Epithelial Tumors.

Authors:  Jin Liu; Ping Yin; Sicong Wang; Tao Liu; Chao Sun; Nan Hong
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

4.  Radiomics Models for the Preoperative Prediction of Pelvic and Sacral Tumor Types: A Single-Center Retrospective Study of 795 Cases.

Authors:  Ping Yin; Xin Zhi; Chao Sun; Sicong Wang; Xia Liu; Lei Chen; Nan Hong
Journal:  Front Oncol       Date:  2021-09-09       Impact factor: 6.244

5.  Clinical-Deep Neural Network and Clinical-Radiomics Nomograms for Predicting the Intraoperative Massive Blood Loss of Pelvic and Sacral Tumors.

Authors:  Ping Yin; Chao Sun; Sicong Wang; Lei Chen; Nan Hong
Journal:  Front Oncol       Date:  2021-10-25       Impact factor: 6.244

6.  Machine and Deep Learning Based Radiomics Models for Preoperative Prediction of Benign and Malignant Sacral Tumors.

Authors:  Ping Yin; Ning Mao; Hao Chen; Chao Sun; Sicong Wang; Xia Liu; Nan Hong
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

Review 7.  State of the Art and New Concepts in Giant Cell Tumor of Bone: Imaging Features and Tumor Characteristics.

Authors:  Anna Parmeggiani; Marco Miceli; Costantino Errani; Giancarlo Facchini
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.